Outcomes evaluation of patients with ESBL- and non–ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program-Reference-Cited by-同舟云学术

Outcomes evaluation of patients with ESBL- and non–ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program

Published:2006-03 Issue:3 Volume:54 Page:231-236
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Bhavnani Sujata M.,Ambrose Paul G.,Craig William A.,Dudley Michael N.,Jones Ronald N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Pharmacokinetics/ pharmacodynamics of cefepime and piperacillin–tazobactam against E. coli and K. pneumoniae producing extended-spectrum beta-lactamase: Report from the ARREST Program;Ambrose;Antimicrob. Agents Chemother.,2003

2. Use of pharmacokinetics–pharmacodynamics and Monte Carlo simulation as decision support for the re-evaluation of NCCLS cephem susceptibility breakpoints for Enterobacteriaceae;Ambrose,2004

3. Impact of extended-spectrum β-lactamase production on the activity of cefepime in a murine-thigh infection model, abstract A-1099;Andes,2001

4. Performance standards for antimicrobial susceptibility testing, 15th Information Supplement. Document M100-S15;Clinical and Laboratory Standards Institute (CLSI),2005

5. Aventis Pharmaceutical Award Lecture: pharmacodynamics and the dosing of antibacterials;Craig,2004

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of ceftriaxone susceptibility testing on the Accelerate Pheno® system of ESBL-producing isolates;Diagnostic Microbiology and Infectious Disease;2020-12

2. АНТИБІОТИКОРЕЗИСТЕНТНІСТЬ УМОВНО-ПАТОГЕННИХ МІКРООРГАНІЗМІВ: АКТУАЛЬНІСТЬ, УМОВИ ВИНИКНЕННЯ, ШЛЯХИ ПОДОЛАННЯ;Інфекційні хвороби;2020-03-20

3. Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis;BMJ Open;2020-01

4. Pathogenic microbes contaminating mobile phones in hospital environment in Northeast India: incidence and antibiotic resistance;Tropical Medicine and Health;2019-12

5. Past and Present Perspectives on β-Lactamases;Antimicrobial Agents and Chemotherapy;2018-10